Decreased bone mineral density in male schizophrenia patients.
Lehman
David
D
Meyer
Jonathan M
JM
D015502:Absorptiometry, Photon; D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D015992:Body Mass Index; D015519:Bone Density / Q000187:drug effects / Q000502:physiology*; D015897:Comorbidity; D003431:Cross-Cultural Comparison; D003865:Major Depressive Disorder / Q000188:drug therapy / Q000453:epidemiology / Q000208:ethnology / Q000503:physiopathology; D005006:Ethnicity / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000453:epidemiology / Q000208:ethnology / Q000503:physiopathology; D011618:Psychotic Disorders / Q000188:drug therapy / Q000453:epidemiology / Q000208:ethnology / Q000503:physiopathology*; D012016:Reference Values; D012307:Risk Factors; D012559:Schizophrenia / Q000188:drug therapy / Q000453:epidemiology / Q000208:ethnology / Q000503:physiopathology*; D013223:Statistics as Topic; D013313:Stress Disorders, Post-Traumatic / Q000188:drug therapy / Q000453:epidemiology / Q000208:ethnology / Q000503:physiopathology
D014150:Antipsychotic Agents